Continuous 14 Day Infusional Ifosfamide for Management of Soft-Tissue and Bone Sarcoma: A Single Centre Retrospective Cohort Analysis

SIMPLE SUMMARY: Ifosfamide is commonly used to treat patients with soft-tissue and bone sarcoma, with greater efficacy observed with higher doses that generally require inpatient treatment and may result in significant myelosuppression and renal toxicity. In the palliative setting, continuous infusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Carter, Thomas J., Milic, Marina, McDerra, Joanna, McTiernan, Anne, Ahmed, Mahbubl, Karavasilis, Vasilios, Michelagnoli, Maria, Windsor, Rachael, Seddon, Beatrice, Whelan, Jeremy, Dileo, Palma, Strauss, Sandra J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698576/
https://www.ncbi.nlm.nih.gov/pubmed/33212978
http://dx.doi.org/10.3390/cancers12113408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698576/
https://www.ncbi.nlm.nih.gov/pubmed/33212978
http://dx.doi.org/10.3390/cancers12113408

Ejemplares similares